Tag: product development

Guangdong, China, June 16, 2026 (GLOBE NEWSWIRE) -- Wing Yip Food Holdings Group Limited (the “Company” or “Wing Yip”) (Nasdaq: WYHG), a meat product processing company in mainland China, today announced that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) on June 16, 2026 that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company’s American Depositary Shares (“ADSs”) to maintain a minimum bid price of US$1.00 per share. As previously disclosed, on December 22, 2025, the Company received a notification from Nasdaq indicating that the closing bid price of the Company’s ADSs had been below US$1.00 per share for the prior 30 consecutive business days and that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2).

FREMONT, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the appointment of Shanker Trivedi to its board of directors, effective immediately.

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.¹ The results showed that TALVEY^® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).¹ Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.¹